According to the ETF Finder at ETF Channel, BMRN makes up 4.39% of the Biotech ETF (BBH) which is up by about 2.5% on the day Wednesday.
In afternoon trading Wednesday, BMRN was up about 2.1% on the day.
It's a wonder to me how split this market really is.
It's been a heavy week for earnings, but Jim Cramer is already looking ahead to next week -- and Apple.
Brineura is first and only treatment for CLN2 disease, a form of Batten disease.